7 articles
CVC and GBL secured a 74.3% stake in Italian pharmaceutical firm Recordati via a €53-a-share bid valued at €11 billion, exceeding their minimum acceptance threshold. They remain short of the 90% delis
Siemens Energy is working with Goldman Sachs to sell a majority stake in its steam turbine business, valued at over €10 billion. Private equity firms including CVC and Bain are considering bids for th
Recordati's board voted 6-4 to accept CVC and GBL's €10.7 billion takeover offer as fair, despite four independent directors dissenting over valuation concerns. The proposed delisting aligns with broa
BC Partners and CVC are among private equity firms eyeing Italian coffee producer Segafredo Zanetti as owner QuattroR weighs a sale. The company projects revenue exceeding €1 billion this year, though
Private equity firms CVC, Cinven, and PAI Partners are bidding for Italian dessert ingredients maker IRCA in a deal potentially valued between €2.5 billion and €3 billion. The transaction highlights i
Private equity firms CVC and GBL launched a €10.7 billion cash bid to take over Italian pharmaceutical group Recordati, offering €51.29 per share. The controlling shareholder has agreed to tender its
CVC Capital Partners agreed to purchase DSM-Firmenich's animal nutrition and health business for €2.2 billion, finalizing the company's shift toward consumer-facing nutrition, health, and beauty opera
ChemBrief